UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(MARK ONE)
☒ QUARTERLY REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarter ended September 30, 2024
☐ TRANSITION REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 001-42252
HCM II ACQUISITION CORP.
(Exact Name of Registrant as Specified in Its Charter)
Cayman Islands | | 98-1785406 |
(State or other jurisdiction of
incorporation or organization) | | (I.R.S. Employer
Identification No.) |
100 First Stamford Place, Suite 330 Stamford, CT | | 06902 |
(Address of principal executive offices) | | (Zip Code) |
(203) 930-2200
(Issuer’s telephone number)
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant | | HONDU | | The Nasdaq Stock Market LLC |
Class A Ordinary Shares, par value $0.0001 per share | | HOND | | The Nasdaq Stock Market LLC |
Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at a price of $11.50 per share | | HONDW | | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes ☐ No ☒
Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes
☒ No ☐
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | | Smaller reporting company | ☒ |
| | Emerging growth company | ☒ |
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐
As of November 13, 2024, there were 23,000,000
Class A ordinary shares, $0.0001 par value and 5,750,000 Class B ordinary shares, $0.0001 par value, issued and outstanding.
HCM II ACQUISITION CORP.
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30,
2024
TABLE OF CONTENTS
PART I - FINANCIAL INFORMATION
Item 1. Interim Financial Statements.
HCM II ACQUISITION CORP.
CONDENSED BALANCE SHEET
SEPTEMBER 30, 2024
(UNAUDITED)
Assets | |
| |
Current assets | |
| |
Cash | |
$ | 825,134 | |
Other receivable | |
| 41,250 | |
Short-term prepaid insurance | |
| 90,250 | |
Prepaid expenses | |
| 60,869 | |
Total current assets | |
| 1,017,503 | |
Long-term prepaid insurance | |
| 75,208 | |
Marketable securities held in Trust Account | |
| 232,499,715 | |
Total Assets | |
$ | 233,592,426 | |
| |
| | |
Liabilities and Shareholders’ Deficit | |
| | |
Current Liabilities | |
| | |
Accrued expenses | |
$ | 246,941 | |
Accrued offering costs | |
| 127,941 | |
Total current liabilities | |
| 374,882 | |
Deferred underwriting fee | |
| 10,720,000 | |
Total Liabilities | |
| 11,094,882 | |
| |
| | |
Commitments and Contingencies (Note 6) | |
| | |
Class A ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of $10.11 per share | |
| 232,499,715 | |
| |
| | |
Shareholders’ Deficit | |
| | |
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | |
| — | |
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; none issued or outstanding (excluding 23,000,000 shares subject to possible redemption) | |
| — | |
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding | |
| 575 | |
Additional paid-in capital | |
| — | |
Accumulated deficit | |
| (10,002,746 | ) |
Total Shareholders’ Deficit | |
| (10,002,171 | ) |
Total Liabilities and Shareholders’ Deficit | |
$ | 233,592,426 | |
The accompanying notes are an integral part of
the unaudited condensed financial statements.
HCM II ACQUISITION CORP.
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
| |
For the Three Months Ended September 30, | | |
For the Period from April 4, 2024 (Inception) Through September 30, | |
| |
2024 | | |
2024 | |
General and administrative costs | |
$ | 278,494 | | |
$ | 331,157 | |
Loss from operations | |
| (278,494 | ) | |
| (331,157 | ) |
| |
| | | |
| | |
Other income: | |
| | | |
| | |
Interest earned on marketable securities held in Trust Account | |
| 1,349,715 | | |
| 1,349,715 | |
Total other income | |
| 1,349,715 | | |
| 1,349,715 | |
| |
| | | |
| | |
Net income | |
$ | 1,071,221 | | |
$ | 1,018,558 | |
| |
| | | |
| | |
Weighted average shares outstanding of Class A ordinary shares | |
| 10,615,385 | | |
| 5,396,648 | |
| |
| | | |
| | |
Basic and diluted net income per ordinary share, Class A ordinary shares | |
$ | 0.07 | | |
$ | 0.09 | |
Weighted average shares outstanding, Class B ordinary shares | |
| 5,750,000 | | |
| 5,621,508 | |
| |
| | | |
| | |
Basic net income per ordinary share, Class B ordinary
shares | |
$ | 0.07 | | |
$ | 0.09 | |
Weighted average shares outstanding, Class B ordinary shares | |
| 5,750,000 | | |
| 5,381,285 | |
| |
| | | |
| | |
Diluted net income per ordinary share, Class B ordinary shares | |
$ | 0.07 | | |
$ | 0.09 | |
The accompanying notes are an integral part of
the unaudited condensed financial statements.
HCM II ACQUISITION CORP.
CONDENSED STATEMENT OF CHANGES IN SHAREHOLDER’S
DEFICIT
(UNAUDITED)
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2024
AND
FOR THE PERIOD FROM APRIL 4, 2024 (INCEPTION)
THROUGH SEPTEMBER 30, 2024
| |
Class A Ordinary Shares | | |
Class B Ordinary Shares | | |
Additional Paid-in | | |
Accumulated | | |
Total Shareholder’s | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance – April 4, 2024 (inception) | |
| — | | |
$ | — | | |
| — | | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Issuance of Class B ordinary shares to Sponsor (1) | |
| — | | |
| — | | |
| 5,750,000 | | |
| 575 | | |
| 24,425 | | |
| — | | |
| 25,000 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Net loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (52,663 | ) | |
| (52,663 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance – June 30, 2024 | |
| — | | |
| — | | |
| 5,750,000 | | |
| 575 | | |
| 24,425 | | |
| (52,663 | ) | |
| (27,663 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Accretion for Class A ordinary shares to redemption amount | |
| — | | |
| — | | |
| — | | |
| — | | |
| (7,348,508 | ) | |
| (11,021,304 | ) | |
| (18,369,812 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Sale of 6,850,000 Private Placement Warrants | |
| — | | |
| — | | |
| — | | |
| — | | |
| 6,850,000 | | |
| — | | |
| 6,850,000 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Fair value of Public Warrants at issuance | |
| — | | |
| — | | |
| — | | |
| — | | |
| 529,000 | | |
| — | | |
| 529,000 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Allocated value of transaction costs | |
| — | | |
| — | | |
| — | | |
| — | | |
| (54,917 | ) | |
| — | | |
| (54,917 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 1,071,221 | | |
| 1,071,221 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance – September 30, 2024 | |
| — | | |
$ | — | | |
| 5,750,000 | | |
$ | 575 | | |
$ | — | | |
$ | (10,002,746 | ) | |
$ | (10,002,171 | ) |
The accompanying notes are an integral part of
the unaudited condensed financial statements.
HCM II ACQUISITION CORP.
CONDENSED STATEMENT OF CASH FLOWS
FOR THE PERIOD FROM APRIL 4, 2024 (INCEPTION)
THROUGH SEPTEMBER 30, 2024
(UNAUDITED)
Cash Flows from Operating Activities: | |
| |
Net income: | |
$ | 1,018,558 | |
Adjustments to reconcile net income to net cash used in operating activities: | |
| | |
Operating costs paid by Sponsor in exchange for issuance of Class B founder shares | |
| 12,463 | |
Payment of operation costs through promissory note | |
| 45,200 | |
Interest earned on marketable securities held in Trust Account | |
| (1,349,715 | ) |
Changes in operating assets and liabilities: | |
| | |
Other receivable | |
| (41,250 | ) |
Prepaid expenses | |
| (60,869 | ) |
Short term prepaid insurance | |
| (90,250 | ) |
Long term prepaid insurance | |
| (75,208 | ) |
Accrued expenses | |
| 246,941 | |
Net cash used in operating activities | |
| (294,130 | ) |
| |
| | |
Cash Flows from Investing Activities: | |
| | |
Investment of cash into Trust Account | |
| (231,150,000 | ) |
Net cash used in investing activities | |
| (231,150,000 | ) |
| |
| | |
Cash Flows from Investing Activities: | |
| | |
Proceeds from sale of Units, net of underwriting discounts paid | |
| 226,000,000 | |
Proceeds from sale of Private Placements Warrants | |
| 6,850,000 | |
Repayment of promissory note - related party | |
| (233,127 | ) |
Payment of offering costs | |
| (347,609 | ) |
Net cash provided by investing activities | |
| 232,269,264 | |
| |
| | |
Net Change in Cash | |
| 825,134 | |
Cash – Beginning of period | |
| — | |
Cash – End of period | |
$ | 825,134 | |
| |
| | |
Noncash investing and financing activities: | |
| | |
Accrued offering costs | |
$ | 127,941 | |
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | |
$ | 12,537 | |
Deferred offering costs paid through promissory note – related party | |
$ | 187,927 | |
Deferred underwriting fee payable | |
$ | 10,720,000 | |
The accompanying notes are an integral part of
the unaudited condensed financial statements.
HCM II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
(Unaudited)
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS
OPERATIONS
HCM II Acquisition Corp. (the
“Company”) is a blank check company incorporated as a Cayman Islands exempted corporation on April 4, 2024. The Company
was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase,
reorganization or similar Business Combination with one or more businesses (the “Business Combination”). As of September
30, 2024, the Company has not selected any specific Business Combination target, and the Company has not, nor has anyone on its
behalf, engaged in any substantive discussions, directly or indirectly, with any Business Combination target with respect to an
initial Business Combination with the Company.
As of September 30, 2024, the Company had not
commenced any operations. All activity for the period from April 4, 2024 (inception) through September 30, 2024 relates to the Company’s
formation and the initial public offering (“Initial Public Offering”), which is described below. The Company will not generate
any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31
as its fiscal year end.
The registration statement for the Company’s
Initial Public Offering was declared effective on August 15, 2024. On August 19, 2024, the Company consummated the Initial Public Offering
of 23,000,000 units (the “Units” and, with respect to the shares of Class A ordinary shares included in the Units being offered,
the “Public Shares”), which includes the full exercise by the underwriters of their over-allotment option in the amount of
3,000,000 Units, at $10.00 per Unit, generating gross proceeds of $230,000,000, which is described in Note 3.
Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of an aggregate of 6,850,000 warrants (the “Private Placement Warrants”)
at a price of $1.00 per Private Placement Warrant, in a private placement to the Company’s sponsor, HCM Investor Holdings II, LLC
(the “Sponsor”), and Cantor Fitzgerald & Co., the representative of the underwriters of the initial Public Offering, generating
gross proceeds of $6,850,000, which is described in Note 4.
Transaction costs amounted to $15,396,014, consisting
of $4,000,000 of cash underwriting fee, $10,720,000 of deferred underwriting fee (see additional discussion in Note 6), and $676,014 of
other offering costs.
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Placement Warrants, although
substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination (less deferred underwriting
commissions).
The Company’s Business Combination must
be with one or more target businesses that together have a fair market value equal to at least 80% of the net balance in the Trust Account
(as defined below) (excluding the amount of deferred underwriting discounts held and taxes payable on the income earned on the Trust Account)
at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination
if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise
acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment
Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully
effect a Business Combination.
HCM II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
(Unaudited)
Following the closing of the Initial Public
Offering, on August 19, 2024, an amount of $231,150,000 ($10.05 per Unit) from the net proceeds of the sale of the Units and the
sale of the Private Placement Warrants was placed in the trust account (the “Trust Account”), with Continental Stock
Transfer & Trust Company acting as trustee and will be invested in U.S. government treasury obligations with a maturity of 185
days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only
in direct U.S. government treasury obligations; the holding of these assets in this form is intended to be temporary and for the
sole purpose of facilitating the intended business combination. To mitigate the risk that might be deemed to be an investment
company for purposes of the Investment Company Act, which risk increases the longer that the Company holds investments in the Trust
Account, the Company may, at any time (based on management team’s ongoing assessment of all factors related to the potential
status under the Investment Company Act), instruct the trustee to liquidate the investments held in the Trust Account and instead to
hold the funds in the Trust Account in cash or in an interest bearing demand deposit account at a bank. Nevertheless, the Company
may be considered to be operating as an investment company and if the Company is deemed as such compliance with additional
regulatory burdens would require additional expenses for which the Company has not allotted funds and would severely hinder the
Company’s ability to compete a business combination. Except with respect to interest earned on the funds held in the Trust Account
that may be released to the Company to pay its taxes, if any, the proceeds from the Initial Public Offering and the sale of the
Private Placement Warrants will not be released from the Trust Account until the earliest of (i) the completion of the
Company’s initial Business Combination, (ii) the redemption of the Company’s public shares if the Company is unable to
complete the initial Business Combination within 24 months from the closing of the Initial Public Offering or by such earlier
liquidation date as the board of directors may approve (the “Completion Window”), subject to applicable law, or (iii)
the redemption of the Company’s public shares properly submitted in connection with a shareholder vote to amend the
Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of the
Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the
Company’s public shares if the Company has not consummated an initial Business Combination within the Completion Window or (B)
with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity.
The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could
have priority over the claims of the Company’s public shareholders.
The Company will provide the Company’s public
shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination
either (i) in connection with a general meeting called to approve the initial Business Combination or (ii) without a shareholder vote
by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination
or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their
shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two
business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust
Account (less taxes payable), divided by the number of then outstanding public shares, subject to the limitations. The amount in the Trust
Account is initially anticipated to be $10.05 per public share.
HCM II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
(Unaudited)
The ordinary shares subject to redemption were
recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with
Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing
Liabilities from Equity.” In such case, if the Company seeks shareholder approval, a majority of the issued and outstanding shares
voted are voted in favor of the Business Combination.
The Company will have only the duration of the
Completion Window to complete the initial Business Combination. However, if the Company is unable to complete its initial Business Combination
within the Completion Window, the Company will as promptly as reasonably possible but not more than ten business days thereafter, redeem
the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
interest earned on the funds held in the Trust Account (less taxes payable and up to $100,000 of interest to pay dissolution expenses),
divided by the number of then outstanding public shares, which redemption will constitute full and complete payment for the public shares
and completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation or other
distributions, if any), subject to the Company’s obligations under Cayman Islands law to provide for claims of creditors and subject
to the other requirements of applicable law.
The Sponsor, officers and directors have entered
into a letter agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their
founder shares and public shares in connection with the completion of the initial Business Combination; (ii) waive their redemption rights
with respect to their founder shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s
amended and restated memorandum and articles of association; (iii) waive their rights to liquidating distributions from the Trust Account
with respect to their founder shares if the Company fails to complete the initial Business Combination within the Completion Window, although
they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails
to complete the initial Business Combination within the Completion Window and to liquidating distributions from assets outside the trust
account; and (iv) vote any founder shares held by them and any public shares purchased during or after the Initial Public Offering (including
in open market and privately negotiated transactions, aside from shares they may purchase in compliance with the requirements of Rule
14e-5 under the Exchange Act, which would not be voted in favor of approving the Business Combination) in favor of the initial Business
Combination.
The Company’s Sponsor has agreed that it
will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company,
or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar
agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.05 per public
share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if
less than $10.05 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not
apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in
the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the
underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended
(the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor
has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes
that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able
to satisfy those obligations.
HCM II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
(Unaudited)
NOTE 2. SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited condensed financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”)
for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities
and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared
in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting.
Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results
of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments,
consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and
cash flows for the periods presented.
The accompanying unaudited condensed financial
statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on
August 16, 2024, as well as the Company’s Current Report on Form 8-K, as filed with the SEC on August 23, 2024. The interim results
for the period from April 4, 2024 (inception) through September 30, 2024, are not necessarily indicative of the results to be expected
for the period ending December 31, 2024 or for any future periods.
Liquidity and Going Concern
As of September 30, 2024, the Company had $825,134
of cash and a working capital of $642,621. In connection with the Company’s assessment of going concern considerations in accordance
with Accounting Standards Codification (“ASC”) 205-40 “Going Concern,” and through the consummation of the Initial
Public Offering, management has determined that the Company currently lacks the liquidity it needs to sustain operations for a reasonable
period of time, which is considered to be at least one year from the date that the unaudited financial statements are issued as it expects
to continue to incur significant costs in pursuit of its acquisition plans. In addition, the Company has until August 19, 2026 to consummate
a Business Combination. It is uncertain whether the Company will be able to consummate a Business Combination by this time. If a Business
Combination is not consummated by August 19, 2026, there will be a mandatory liquidation and subsequent dissolution. No adjustments have
been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after August 19, 2026. The Company
intends to continue to seek to complete a Business Combination before the mandatory liquidation date.
Emerging Growth Company
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements
of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and
proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder
approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but
any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that
when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging
growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth
company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.
HCM II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
(Unaudited)
Use of Estimates
The preparation of financial statements in conformity
with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting
period. Actual results could differ from those estimates..
Cash and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company had $825,134 in cash equivalents
as of September 30, 2024.
Marketable Securities held in Trust Account
As of September 30, 2024, the assets held in the
Trust Account, amounting to $232,499,715, were held in a Money Market Mutual Fund.
Offering Costs
The Company complies with the requirements of
the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Deferred offering costs consist principally
of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, “Debt with Conversion and
Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components.
The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and warrants,
using the residual method by allocating Initial Public Offering proceeds first to assigned value of the warrants and then to the Class
A ordinary shares. Offering costs allocated to the Class A ordinary shares were charged to temporary equity and offering costs allocated
to the Public and Private Placement Warrants were charged to shareholders’ equity as Public and Private Placement Warrants after
management’s evaluation were accounted for under equity treatment.
Fair Value of Financial Instruments
The fair value of the Company’s assets and
liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates
the carrying amounts represented in the balance sheet, primarily due to their short-term nature.
Concentration of Credit Risk
Financial instruments that potentially subject
the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal
Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant
adverse impact on the Company’s financial condition, results of operations, and cash flows.
Income Taxes
The Company accounts for income taxes under ASC
Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income
taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets
and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods
in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the
financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to
be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s
management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and
penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2024, there were no unrecognized tax benefits
and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in
significant payments, accruals or material deviation from its position.
The Company is considered to be an exempted Cayman
Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing
requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.
HCM II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
(Unaudited)
Net Income per Ordinary Share
The Company complies with accounting and disclosure
requirements of FASB ASC Topic 260, “Earnings Per Share.” Net income per ordinary share is computed by dividing net income
by the weighted average number of shares of ordinary shares outstanding for the period. The Company has two classes of ordinary shares,
which are referred to as redeemable Class A Ordinary Shares and non-redeemable Class B ordinary shares. Accretion associated
with the redeemable shares of Class A Ordinary Shares is excluded from income per ordinary share as the redemption value approximates
fair value.
The following tables reflects the calculation of
basic and diluted net income per ordinary share (in dollars, except per share amounts):
| |
For the Three Months Ended September 30 , | | |
For the Period from April 4, 2024 (Inception) Through September 30, | |
| |
2024 | | |
2024 | |
| |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Basic net income per ordinary share | |
| | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| |
Allocation of net income | |
$ | 694,846 | | |
$ | 376,375 | | |
$ | 498,886 | | |
$ | 519,672 | |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Basic weighted average shares outstanding | |
| 10,615,385 | | |
| 5,750,000 | | |
| 5,396,648 | | |
| 5,621,508 | |
Basic net income per ordinary share | |
$ | 0.07 | | |
$ | 0.07 | | |
$ | 0.09 | | |
$ | 0.09 | |
| |
For the Three Months Ended September 30 , | | |
For the Period from April 4, 2024 (Inception) Through September 30, | |
| |
2024 | | |
2024 | |
| |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Diluted net income per ordinary share | |
| | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| |
Allocation of net income | |
$ | 694,846 | | |
$ | 376,375 | | |
$ | 510,005 | | |
$ | 508,553 | |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Diluted weighted average shares outstanding | |
| 10,615,385 | | |
| 5,750,000 | | |
| 5,396,648 | | |
| 5,381,285 | |
Diluted net income per ordinary share | |
$ | 0.07 | | |
$ | 0.07 | | |
$ | 0.09 | | |
$ | 0.09 | |
Warrant Instruments
The Company accounted for the 11,500,000 Public
and 6,850,000 Private Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the
guidance contained in FASB ASC Topic 815, “Derivatives and Hedging”. Accordingly, the Company evaluated and classified the
warrant instruments under equity treatment at their assigned values. Such guidance provides that the warrants described above were not
precluded from equity classification. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent
changes in fair value are not recognized as long as the contracts continue to be classified in equity in accordance with ASC 480 and ASC
815.
Class A Redeemable Share Classification
The public shares contain a redemption feature
which allows for the redemption of such public shares in connection with the Company’s liquidation, or if there is a shareholder
vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company
classifies public shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control
of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable
shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering,
the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable
shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of
September 30, 2024, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside
of the shareholders’ deficit section of the Company’s balance sheet. As of September 30, 2024, the Class A ordinary shares
subject to redemption reflected in the balance sheet are reconciled in the following table:
Gross proceeds | |
$ | 230,000,000 | |
Less: | |
| | |
Proceeds allocated to Public Warrants | |
| (529,000 | ) |
Class A ordinary shares issuance costs | |
| (15,341,097 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 18,369,812 | |
Class A ordinary shares subject to possible redemption, September 30, 2024 | |
$ | 232,499,715 | |
HCM II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
(Unaudited)
Recent Accounting Pronouncements
Management does not believe that any recently
issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.
NOTE 3. INITIAL PUBLIC OFFERING
Pursuant to the Initial Public Offering, on August
19, 2024 the Company sold 23,000,000 Units, which includes the full exercise by the underwriters of their over-allotment option in the
amount of 3,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-half of one redeemable
Public Warrant. Each Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject
to adjustment (see Note 4). Each warrant will become exercisable 30 days after the completion of the initial Business Combination and
will expire five years after the completion of the initial Business Combination, or earlier upon redemption or liquidation.
Warrants—As of September 30, 2024,
there were 18,350,000 warrants outstanding, including 11,500,000 Public Warrants and 6,850,000 Private Placement Warrants. Each whole
warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as
discussed herein. The warrants cannot be exercised until 30 days after the completion of the initial Business Combination,
and will expire at 5:00 p.m., New York City time, five years after the completion of the initial Business Combination or earlier
upon redemption or liquidation.
The Company will not be obligated to deliver any
Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration
statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus
relating thereto is current. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon
exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to
be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions
in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled
to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company be required to net cash
settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing
such warrant will have paid the full purchase price for the unit solely for the Class A ordinary share underlying such unit.
Under the terms of the warrant agreement, the
Company has agreed that, as soon as practicable, but in no event later than 20 business days, after the closing of its Business Combination,
it will use commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement for the Initial
Public Offering or a new registration statement covering the registration under the Securities Act of the Class A ordinary shares issuable
upon exercise of the warrants and thereafter will use its commercially reasonable efforts to cause the same to become effective within
60 business days following the Company’s initial Business Combination and to maintain a current prospectus relating to the Class
A ordinary shares issuable upon exercise of the warrants until the expiration of the warrants in accordance with the provisions of the
warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective
by the sixtieth 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there
is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement,
exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding
the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such
that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at
its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with
Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in
effect a registration statement, and in the event the Company does not so elect, the Company will use its commercially reasonable efforts
to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
If the holders exercise their public warrants
on a cashless basis, they would pay the warrant exercise price by surrendering the warrants for that number of Class A ordinary shares
equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied
by the excess of the “fair market value” of the Class A ordinary shares over the exercise price of the warrants by (y) the
fair market value. The “fair market value” is the average reported closing price of the Class A ordinary shares for the 10
trading days ending on the third trading day prior to the date on which the notice of exercise is received by the warrant agent or on
which the notice of redemption is sent to the holders of warrants, as applicable.
HCM II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
(Unaudited)
Redemption of Warrants When the Price per Class
A Ordinary Share Equals or Exceeds $18.00: The Company may redeem the outstanding warrants:
Once the warrants become exercisable, the Company
may redeem the outstanding warrants (except as described herein with respect to the private placement warrants):
|
● |
in whole and not in part; |
| ● | at a price of $0.01 per warrant; |
| ● | upon a minimum of 30 days’ prior written notice of redemption (the “30-day redemption period”); and |
| ● | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30-trading day period commencing at least 30 days after completion of the initial business combination and ending three business days before we send the notice of redemption to the warrant holders. |
Additionally, if the number of outstanding Class
A ordinary shares is increased by a share capitalization payable in Class A ordinary shares, or by a subdivision of ordinary shares or
other similar event, then, on the effective date of such share capitalization, subdivision or similar event, the number of Class A ordinary
shares issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding ordinary shares. A rights
offering made to all or substantially all holders of ordinary shares entitling holders to purchase Class A ordinary shares at a price
less than the fair market value will be deemed a share capitalization of a number of Class A ordinary shares equal to the product of (i)
the number of Class A ordinary shares actually sold in such rights offering (or issuable under any other equity securities sold in such
rights offering that are convertible into or exercisable for Class A ordinary shares) and (ii) the quotient of (x) the price per Class
A ordinary share paid in such rights offering and (y) the fair market value. For these purposes (i) if the rights offering is for securities
convertible into or exercisable for Class A ordinary shares, in determining the price payable for Class A ordinary shares, there will
be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion
and (ii) fair market value means the volume weighted average price of Class A ordinary shares as reported during the ten (10) trading
day period ending on the trading day prior to the first date on which the Class A ordinary shares trade on the applicable exchange or
in the applicable market, regular way, without the right to receive such rights.
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the closing of the Initial
Public Offering, the Sponsor and Cantor Fitzgerald & Co. purchased an aggregate of 6,850,000 warrants, each exercisable to purchase
one Class A ordinary share at $11.50 per share, at a price of $1.00 per warrant, or $6,850,000 in the aggregate, in a private placement.
Of those 6,850,000 Private Placement Warrants, the Sponsor purchased 4,275,000 Private Placement Warrants and Cantor Fitzgerald &
Co. purchased 2,575,000 Private Placement Warrants. Each whole warrant entitles the registered holder to purchase one Class A ordinary
share at a price of $11.50 per share, subject to adjustment.
HCM II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
(Unaudited)
The Private Placement Warrants were identical
to the Public Warrants sold in the Initial Public Offering except that, so long as they are held by the Sponsor, Cantor Fitzgerald &
Co. or their permitted transferees, the Private Placement Warrants (i) may not (including the Class A ordinary shares issuable upon exercise
of these Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30
days after the completion of the initial Business Combination, (ii) will be entitled to registration rights and (iii) with respect to
private placement warrants held by Cantor Fitzgerald & Co. and/or its designees, will not be exercisable more than five years from
the commencement of sales in this offering in accordance with Financial Industry Regulatory Authority (“FINRA”) Rule 5110(g)(8).
The Sponsor, officers and directors have entered
into a letter agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their
founder shares and public shares in connection with the completion of the initial Business Combination; (ii) waive their redemption rights
with respect to their founder shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s
amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to
allow redemption in connection with the initial Business Combination or to redeem 100% of the public shares if the Company has not consummated
an initial Business Combination within the Completion Window or (B) with respect to any other material provisions relating to shareholders’
rights or pre-initial Business Combination activity; (iii) waive their rights to liquidating distributions from the Trust Account with
respect to their founder shares if the Company fails to complete the initial Business Combination within the Completion Window, although
they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails
to complete the initial Business Combination within the Completion Window and to liquidating distributions from assets outside the trust
account; and (iv) vote any founder shares held by them and any public shares purchased during or after the Initial Public Offering (including
in open market and privately negotiated transactions, aside from shares they may purchase in compliance with the requirements of Rule
14e-5 under the Exchange Act, which would not be voted in favor of approving the Business Combination) in favor of the initial Business
Combination.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On April 8, 2024, the Sponsor made a capital contribution
of $25,000, or approximately $0.004 per share, to cover certain of the Company’s expenses, for which the Company issued 5,750,000
founders shares to the Sponsor. Up to 750,000 of the founder shares may be surrendered by the Sponsor for no consideration depending on
the extent to which the underwriters’ over-allotment is exercised. On August 19, 2024, the underwriters exercised their over-allotment
option in full as part of the closing of the Initial Public Offering. As such, the 750,000 founder shares are no longer subject to forfeiture.
The Company’s initial shareholders have
agreed not to transfer, assign or sell any of their founder shares and any Class A ordinary shares issued upon conversion thereof until
the earlier to occur of (i) one year after the completion of the initial Business Combination or (ii) the date on which the Company completes
a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s
shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Any permitted transferees
will be subject to the same restrictions and other agreements of the Company’s initial shareholders with respect to any founder
shares (the “Lock-up”). Notwithstanding the foregoing, if (1) the closing price of the Class A ordinary shares equals or exceeds
$12.00 per share (as adjusted for share subdivision, share capitalizations, reorganizations, recapitalizations and the like) for any 20
trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination or (2) if the Company
consummates a transaction after the initial Business Combination which results in the Company’s shareholders having the right to
exchange their shares for cash, securities or other property, the founder shares will be released from the Lock-up.
HCM II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
(Unaudited)
Promissory Note—Related Party
The Sponsor has agreed to loan the Company an
aggregate of up to $300,000 to be used for a portion of the expenses of the Initial Public Offering. The loan is non-interest bearing,
unsecured and due at the earlier of December 31, 2024 or the closing of the Initial Public Offering. The Company repaid all the outstanding
balance of the note at the closing of the Initial Public Offering on August 19, 2024. Borrowings under the note are no longer available.
Administrative Services Agreement
The Company entered into an agreement, commencing
on August 15, 2024, through the earlier of consummation of the initial Business Combination and the liquidation, to pay the Sponsor $15,000
per month for office space, utilities and secretarial and administrative support services. For the period from April 4, 2024 (inception)
through September 30, 2024, the Company incurred $17,500 for these services.
Related Party Loans
In order to finance transaction costs in connection
with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may,
but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes
a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the
Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from
the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible
into private placement warrants of the post Business Combination entity at a price of $1.00 per warrant at the option of the lender. The
warrants would be identical to the Private Placement Warrants. As of September 30, 2024, no such Working Capital Loans were outstanding.
NOTE 6. COMMITMENTS AND CONTINGENCIES
Risks and Uncertainties
The United States and global markets are experiencing
volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the recent escalation
of the Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (“NATO”)
deployed additional military forces to Eastern Europe, and the United States, the United Kingdom, the European Union and other countries
have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal
of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication (SWIFT) payment system. Certain
countries, including the United States, have also provided and may continue to provide military aid or other assistance to Ukraine and
to Israel, increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the escalation of the Israel-Hamas
conflict and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom,
the European Union, Israel and its neighboring states and other countries have created global security concerns that could have a lasting
impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could
lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain
interruptions and increased cyberattacks against U.S. companies. Additionally, any resulting sanctions could adversely affect the global
economy and financial markets and lead to instability and lack of liquidity in capital markets.
Any of the above-mentioned factors, or any other
negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine,
the escalation of the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect the Company’s search
for an initial Business Combination and any target business with which the Company may ultimately consummate an initial Business Combination.
Registration Rights
The holders of the founder shares, Private Placement
Warrants and the Class A ordinary shares underlying such Private Placement Warrants and Private Placement Warrants and warrants that may
be issued upon conversion of the Working Capital Loans will have registration rights to require the Company to register a sale of any
of the Company’s securities held by them and any other securities of the Company acquired by them prior to the consummation of the
initial Business Combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial
Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company
registers such securities. In addition, the holders have certain piggyback registration rights with respect to registration statements
filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with
the filing of any such registration statements.
HCM II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
(Unaudited)
Underwriter’s Agreement
The underwriters have a 45-day option from the
date of the Initial Public Offering to purchase up to an additional 3,000,000 units to cover over-allotments, if any. On August 19,
2024, simultaneously with the closing of the Initial Public Offering, the underwriters elected to fully exercise the over-allotment option
to purchase the additional 3,000,000 Units at a price of $10.00 per Unit.
The underwriters were entitled to a cash underwriting
discount of $4,000,000 (2.0% of the gross proceeds of the units offered in the Initial Public Offering, excluding any proceeds from units
sold pursuant to the underwriters’ over-allotment option). Additionally, the underwriters are entitled to a deferred underwriting
discount of 4.40% of the gross proceeds of the Initial Public Offering held in the Trust Account other than those sold pursuant to the
underwriters over-allotment option and 6.40% of the gross proceeds sold pursuant to the underwriter’s over-allotment option, $10,720,000
in the aggregate, payable upon the completion of the Company’s initial Business Combination subject to the terms of the underwriting
agreement. At September 30, 2024, the balance of the deferred underwriting fee payable was $10,720,000
NOTE 7. SHAREHOLDER’S DEFICIT
Preference Shares—The Company
is authorized to issue a total of 1,000,000 preference shares at par value of $0.0001 each. As of September 30, 2024,
there were no shares of preference shares issued or outstanding.
Class A Ordinary Shares—The
Company is authorized to issue a total of 200,000,000 Class A ordinary shares at par value of $0.0001 each. As of September
30, 2024, there were no shares of Class A ordinary shares issued or outstanding, excluding 23,000,000 Class A ordinary shares subject
to possible redemption.
Class B Ordinary Shares—The
Company is authorized to issue a total of 20,000,000 Class B ordinary shares at par value of $0.0001 each. On April
8, 2024, the Company issued 5,750,000 Class B ordinary shares to the Sponsor for $25,000, or approximately $0.004 per share. As of September
30, 2024, there were 5,750,000 Class B ordinary shares issued and outstanding.
The founder shares will automatically convert
into Class A ordinary shares concurrently with or immediately following the consummation of the initial Business Combination or earlier
at the option of the holder on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, reorganizations,
recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares,
or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in this offering and related to or in
connection with the closing of the initial Business Combination, the ratio at which Class B ordinary shares convert into Class A ordinary
shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with
respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B
ordinary shares will equal, in the aggregate, 20% of the sum of (i) the total number of all Class A ordinary shares outstanding upon the
completion of this offering (including any Class A ordinary shares issued pursuant to the underwriters’ over-allotment option and
excluding the Class A ordinary shares underlying the private placement warrants issued to the sponsor), plus (ii) all Class A ordinary
shares and equity-linked securities issued or deemed issued, in connection with the closing of the initial Business Combination (excluding
any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent
warrants issued to the Sponsor or any of its affiliates or to the Company’s officers or directors upon conversion of working capital
loans) minus (iii) any redemptions of Class A ordinary shares by public shareholders in connection with an initial Business Combination;
provided that such conversion of founder shares will never occur on a less than one-for-one basis.
Holders of record of the Company’s Class
A ordinary shares and Class B ordinary shares are entitled to one vote for each share held on all matters to be voted on by shareholders.
Unless specified in the amended and restated memorandum and articles of association or as required by the Companies Act or stock exchange
rules, an ordinary resolution under Cayman Islands law and the amended and restated memorandum and articles of association, which requires
the affirmative vote of at least a majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where
proxies are allowed, by proxy at the applicable general meeting of the Company is generally required to approve any matter voted on by
shareholders. Approval of certain actions requires a special resolution under Cayman Islands law, which (except as specified below) requires
the affirmative vote of at least two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person or, where
proxies are allowed, by proxy at the applicable general meeting, and pursuant to the amended and restated memorandum and articles of association,
such actions include amending the amended and restated memorandum and articles of association and approving a statutory merger or consolidation
with another the company. There is no cumulative voting with respect to the appointment of directors, meaning, following the initial Business
Combination, the holders of more than 50% of the ordinary shares voted for the appointment of directors can elect all of the directors.
Prior to the consummation of the initial Business Combination, only holders of the Class B ordinary shares will (i) have the right to
vote on the appointment and removal of directors and (ii) be entitled to vote on continuing the company in a jurisdiction outside the
Cayman Islands (including any special resolution required to amend the constitutional documents or to adopt new constitutional documents,
in each case, as a result of the approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). Holders of
the Class A ordinary shares will not be entitled to vote on these matters during such time. These provisions of the amended and restated
memorandum and articles of association may only be amended if approved by a special resolution passed by the affirmative vote of at least
90% (or, where such amendment is proposed in respect of the consummation of the initial Business Combination, two-thirds) of the votes
cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general
meeting of the Company.
HCM II ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2024
(Unaudited)
NOTE 8. Fair Value Measurements
The fair value of the Company’s financial
assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale
of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the
measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of
observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities
based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
|
Level 1: |
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
|
|
|
|
Level 2: |
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |
|
|
|
|
Level 3: |
Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability. |
The following table presents information about the Company’s
assets that are measured at fair value on September 30, 2024, and indicates the fair value hierarchy of the valuation inputs the Company
utilized to determine such fair value:
| |
Level | |
September 30, 2024 | |
Assets: | |
| |
| |
Money market mutual fund held in Trust Account | |
1 | |
$ | 232,499,715 | |
The following table presents information about the Company’s
assets that are measured at fair value on August 19, 2024, and indicates the fair value hierarchy of the valuation inputs the Company
utilized to determine such fair value:
| |
Level | |
August 19, 2024 | |
Equity: | |
| |
| |
Fair value of Public Warrants for Class A ordinary shares subject to redemption allocation | |
3 | |
$ | 529,000 | |
The fair value of Public Warrants was determined
using Monte Carlo Simulation Model. The Public Warrants have been classified within shareholders’ deficit and will not require remeasurement
after issuance. The following table presents the quantitative information regarding market assumptions used in the valuation of the Public
Warrants:
| |
August 19, 2024 | |
Underlying share price | |
$ | 9.98 | |
Exercise price | |
$ | 11.50 | |
Term (years) | |
| 7.0 | |
Risk-free rate | |
| 3.78 | % |
Volatility | |
| 9.0 | % |
The Company accounted for warrants issued at the
IPO under equity treatment, as such, no subsequent re-measurement is required.
NOTE 9. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions
that occurred after the unaudited condensed balance sheet date up to the date that the unaudited condensed financial statements were issued.
Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment
or disclosure in the unaudited condensed financial statements.
On October 10, 2024, the Company announced that,
commencing on October 10, 2024, the holders of units issued in its Initial Public Offering may elect to separately trade shares of Class
A ordinary shares and warrants included in the Units. No fractional warrants will be issued upon separation of the Units and only whole
warrants will trade. The Units not separated will continue to trade on the Nasdaq under the symbol “HONDU.” Shares of Class
A ordinary shares and the warrants are expected to trade on the Nasdaq under the symbols “HOND” and “HONDW,” respectively.
Item 2. Management’s Discussion and Analysis
of Financial Condition and Results of Operations
References in this report (the “Quarterly
Report”) to “we,” “us” or the “Company” refer to HCM II Acquisition Corp. References to our
“management” or our “management team” refer to our officers and directors, and references to the “Sponsor”
refer to HCM Investor Holdings II, LLC. The following discussion and analysis of the Company’s financial condition and results of
operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report.
Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and
uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking
statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical
facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All
statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Proposed Business Combination
(as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations,
are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,”
“estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking
statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs,
based on information currently available. A number of factors could cause actual events, performance or results to differ materially from
the events, performance and results discussed in the forward-looking statements, including that the conditions of the Proposed Business
Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from
those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus
for its Initial Public Offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities
filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities
law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information,
future events or otherwise.
Overview
We are a blank check company incorporated in the
Cayman Islands on April 4, 2024 formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase,
reorganization or other similar Business Combination with one or more businesses. We intend to effectuate our Business Combination using
cash derived from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our shares, debt or a combination
of cash, shares and debt.
We expect to continue to incur significant costs
in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor
generated any revenues to date. Our only activities from April 4, 2024 (inception) through September 30, 2024 were organizational activities,
those necessary to prepare for the Initial Public Offering, described below, and identifying a target company for a Business Combination.
We do not expect to generate any operating revenues until after the completion of our Business Combination. Subsequent to the Initial
Public Offering, we generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We
incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as
for due diligence expenses.
For the three months ended September 30, 2024,
we had net income of $1,071,221 which consists of interest earned on marketable securities held in the trust account of $1,349,715, offset
by operating costs of $278,494.
For the period from April 4, 2024 (inception)
through September 30, 2024, we had net income of $1,018,558 which consists of interest earned on cash and marketable securities held in
the trust account of $1,349,715, offset by operating costs of $331,157.
Liquidity and Capital Resources
Until the consummation of the Initial Public Offering,
our only source of liquidity was an initial purchase of shares of Class B ordinary shares, par value $0.0001 per share, by the Sponsor
and loans from the Sponsor.
Subsequent to the quarterly period covered by
this Quarterly Report on Form 10-Q, on August 19, 2024, we consummated the Initial Public Offering of 23,000,000 Units at $10.00 per Units,
which includes the full exercise by the underwriters of their over-allotment option in the amount of 3,000,000 Units generating gross
proceeds of $230,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of an aggregate of 6,850,000
Private Placement Warrants at a price of $1.00 per Private Placement Warrant, in a private placement to the Sponsor and Cantor Fitzgerald
& Co., generating gross proceeds of $6,850,000.
We intend to use substantially all of the funds
held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete
our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our
Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the
target business or businesses, make other acquisitions and pursue our growth strategies.
We intend to use the funds held outside the Trust
Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel
to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate
documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
For the period from April 4, 2024 (inception)
through September 30, 2024, cash used in operating activities was $294,130. Net income of $1,018,558 was affected by operating costs paid
by Sponsor in exchange for issuance of Class B founder shares of $12,463, payment of operation costs through promissory note of $45,200
and interest earned on marketable securities held in the trust account of $1,349,715. Changes in operating assets and liabilities was
affected by $20,636 of cash provided for operating activities.
As of September 30, 2024, we had marketable securities
held in the trust account of $232,499,715. We intend to use substantially all of the funds held in the Trust Account, including any amounts
representing interest earned on the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that
our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds
held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions
and pursue our growth strategies.
As of September 30, 2024, we had cash held outside
of the trust account of $825,134 available for working capital needs. We intend to use the funds held outside the Trust Account primarily
to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices,
plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material
agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies
or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their
affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such
loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the
Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of
such Working Capital Loans may be convertible into private placement warrants of the post Business Combination entity at a price of $1.00
per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants.
We do not believe we will need to raise additional
funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target
business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so,
we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional
financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares
upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such
Business Combination.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities,
which would be considered off-balance sheet arrangements as of September 30, 2024. We do not participate in transactions that create relationships
with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established
for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual obligations
We do not have any long-term debt, capital lease
obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the Sponsor a total of $15,000 per month
for office space, utilities and secretarial and administrative support services.
The underwriters have a 45-day option from the
date of the Initial Public Offering to purchase up to an additional 3,000,000 units to cover over-allotments, if any. On August 19,
2024, simultaneously with the closing of the Initial Public Offering, the underwriters elected to fully exercise the over-allotment option
to purchase the additional 3,000,000 Units at a price of $10.00 per Unit.
Critical Accounting Estimates
The preparation of condensed financial statements
and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities
at the date of the financial statements, and income and expenses during the periods reported. Making estimates requires management to
exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of
circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change
in the near term due to one or more future confirming events. Accordingly, the actual results could materially differ from those estimates.
As of September 30, 2024, we did not have any critical accounting estimates to be disclosed.
Item 3. Quantitative and Qualitative Disclosures
About Market Risk
Not required for smaller reporting companies.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are controls
and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange
Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls
and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our
reports filed or submitted under the Exchange Act is accumulated and communicated to Management, including our Chief Executive Officer
and Chief Financial Officer (together, the “Certifying Officers”), or persons performing similar functions, as appropriate,
to allow timely decisions regarding required disclosure.
Under the supervision and with the participation
of our Management, including our Certifying Officers, we carried out an evaluation of the effectiveness of the design and operation of
our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our
Certifying Officers concluded that our disclosure controls and procedures were effective as of the end of the quarterly period ended September
30, 2024.
Changes in Internal Control over Financial
Reporting
There was no change in our internal control over
financial reporting that occurred during the fiscal quarter of 2024 covered by this Quarterly Report on Form 10-Q that has materially
affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
None
Item 1A. Risk Factors
Factors that could cause our actual results to
differ materially from those in this report include the risk factors described in our final prospectus for its Initial Public Offering
filed with the SEC. As of the date of this Report, there have been no material changes to the risk factors disclosed in our final prospectus
for its Initial Public Offering filed with the SEC.
Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds.
On August 19, 2024, we consummated our Initial
Public Offering of 23,000,000 Units, including 3,000,000 Units issued pursuant to the full exercise of the underwriter of its over-allotment
option. Each Unit consists of one Class A ordinary share, par value $0.0001 per share (“Class A Ordinary Shares”), and one-half
of one redeemable warrant of the Company (“Warrant”), with each whole Warrant entitling the holder thereof to purchase one
Class A ordinary share for $11.50 per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company
of $230,000,000.
Simultaneously with the closing of the Initial
Public Offering, pursuant to the Warrant Purchase Agreements, we completed the private sale of an aggregate of 6,850,000 warrants to the
Sponsor and the Underwriter at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds of $6,850,000. The Private
Placement Warrants are identical to the Warrants included in the Units sold as part of the Units in the Initial Public Offering, except
as otherwise disclosed in the Registration Statement. No underwriting discounts or commissions were paid with respect to such sale. The
issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities
Act of 1933, as amended.
Of the gross proceeds received from the Initial
Public Offering and the proceeds of the sale of the Private Placement Warrants, an aggregate of $231,150,000 was placed in the Trust Account.
We incurred a total of $15,396,014, consisting
of $4,000,000 of cash underwriting fee, $10,720,000 of deferred underwriting fee and $676,014 of other offering costs.
For a description of the use of the proceeds generated
in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q.
Item 3. Defaults Upon Senior Securities
None
Item 4. Mine Safety Disclosures
None
Item 5. Other Information
None
Item 6. Exhibits
The following exhibits are filed as part of, or
incorporated by reference into, this Quarterly Report on Form 10-Q.
No. |
|
Description of Exhibit |
1.1 |
|
Underwriting Agreement, dated August 15, 2024, by and between the Company and Cantor Fitzgerald & Co.(1) |
3.1 |
|
Amended and Restated Memorandum and Articles of Association.(1) |
4.1 |
|
Warrant Agreement, dated August 15, 2024, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent.(1) |
10.1 |
|
Investment Management Trust Agreement, dated August 15, 2024, by and between the Company and Continental Stock Transfer & Trust Company, as trustee.(1) |
10.2 |
|
Registration Rights Agreement, dated August 15, 2024, by and among the Company, the Sponsor and the Underwriter.(1) |
10.3(a) |
|
Private Placement Warrants Purchase Agreement, dated August 15, 2024, by and between the Company and the Sponsor.(1) |
10.3(b) |
|
Private Placement Warrants Purchase Agreement, dated August 15, 2024, by and between the Company and the Underwriter.(1) |
10.4 |
|
Letter Agreement, dated August 15, 2024, by and among the Company, its officers, its directors and the Sponsor.(1) |
10.5 |
|
Administrative Support Agreement, dated August 15, 2024, between the Company and the Sponsor.(1) |
31.1* |
|
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
31.2* |
|
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
32.1** |
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
32.2** |
|
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
101.INS |
|
Inline XBRL Instance Document. |
101.SCH |
|
Inline XBRL Taxonomy Extension Schema Document. |
101.CAL |
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
101.DEF |
|
Inline XBRL Taxonomy Extension Definition Linkbase Document. |
101.LAB |
|
Inline XBRL Taxonomy Extension Label Linkbase Document. |
101.PRE |
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
104 |
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
** |
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
| (1) | Previously filed as an exhibit to our Current Report on Form
8-K filed on August 20, 2024, and incorporated by reference herein. |
PART III - SIGNATURES
In accordance with the requirements
of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
HCM II ACQUISITION CORP. |
|
|
|
Date:
November 13, 2024 |
By: |
/s/ Shawn Matthews |
|
Name: |
Shawn Matthews |
|
Title: |
Chief Executive Officer |
|
|
(Principal Executive Officer) |
|
|
|
Date: November 13,
2024 |
By: |
/s/ Steven Bischoff |
|
Name: |
Steven Bischoff |
|
Title: |
Chief Financial Officer |
|
|
(Principal Financial and Accounting Officer) |
22
false
--12-31
Q3
0002019804
0002019804
2024-04-04
2024-09-30
0002019804
hondu:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember
2024-04-04
2024-09-30
0002019804
hondu:ClassAOrdinarySharesParValue00001PerShareMember
2024-04-04
2024-09-30
0002019804
hondu:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAPriceOf1150PerShareMember
2024-04-04
2024-09-30
0002019804
us-gaap:CommonClassAMember
2024-11-13
0002019804
us-gaap:CommonClassBMember
2024-11-13
0002019804
2024-09-30
0002019804
us-gaap:CommonClassAMember
2024-09-30
0002019804
us-gaap:CommonClassBMember
2024-09-30
0002019804
2024-07-01
2024-09-30
0002019804
us-gaap:CommonClassAMember
2024-07-01
2024-09-30
0002019804
us-gaap:CommonClassAMember
2024-04-04
2024-09-30
0002019804
us-gaap:CommonClassBMember
2024-07-01
2024-09-30
0002019804
us-gaap:CommonClassBMember
2024-04-04
2024-09-30
0002019804
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2024-04-03
0002019804
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2024-04-03
0002019804
us-gaap:AdditionalPaidInCapitalMember
2024-04-03
0002019804
us-gaap:RetainedEarningsMember
2024-04-03
0002019804
2024-04-03
0002019804
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2024-04-04
2024-06-30
0002019804
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2024-04-04
2024-06-30
0002019804
us-gaap:AdditionalPaidInCapitalMember
2024-04-04
2024-06-30
0002019804
us-gaap:RetainedEarningsMember
2024-04-04
2024-06-30
0002019804
2024-04-04
2024-06-30
0002019804
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2024-06-30
0002019804
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2024-06-30
0002019804
us-gaap:AdditionalPaidInCapitalMember
2024-06-30
0002019804
us-gaap:RetainedEarningsMember
2024-06-30
0002019804
2024-06-30
0002019804
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2024-07-01
2024-09-30
0002019804
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2024-07-01
2024-09-30
0002019804
us-gaap:AdditionalPaidInCapitalMember
2024-07-01
2024-09-30
0002019804
us-gaap:RetainedEarningsMember
2024-07-01
2024-09-30
0002019804
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2024-09-30
0002019804
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2024-09-30
0002019804
us-gaap:AdditionalPaidInCapitalMember
2024-09-30
0002019804
us-gaap:RetainedEarningsMember
2024-09-30
0002019804
us-gaap:CommonClassAMember
us-gaap:IPOMember
2024-08-19
2024-08-19
0002019804
us-gaap:CommonClassAMember
us-gaap:OverAllotmentOptionMember
2024-08-19
2024-08-19
0002019804
us-gaap:CommonClassAMember
us-gaap:IPOMember
2024-08-19
0002019804
hondu:PrivatePlacementWarrantsMember
2024-04-04
2024-09-30
0002019804
hondu:PrivatePlacementWarrantsMember
2024-09-30
0002019804
hondu:PrivatePlacementWarrantsMember
hondu:CantorFitzgeraldCoMember
2024-04-04
2024-09-30
0002019804
us-gaap:IPOMember
2024-09-30
0002019804
hondu:PrivatePlacementWarrantsMember
us-gaap:IPOMember
2024-08-19
2024-08-19
0002019804
hondu:PrivatePlacementWarrantsMember
us-gaap:IPOMember
2024-08-19
0002019804
hondu:BusinessCombinationMember
2024-09-30
0002019804
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
hondu:PrivatePlacementWarrantsMember
us-gaap:IPOMember
2024-09-30
0002019804
hondu:PublicWarrantsMember
2024-09-30
0002019804
hondu:PrivateWarrantsMember
2024-09-30
0002019804
hondu:OrdinarySharesSubjectToRedemptionMember
2024-04-04
2024-09-30
0002019804
hondu:OrdinarySharesSubjectToRedemptionMember
2024-09-30
0002019804
us-gaap:IPOMember
2024-08-19
2024-08-19
0002019804
us-gaap:OverAllotmentOptionMember
2024-08-19
2024-08-19
0002019804
us-gaap:IPOMember
2024-08-19
0002019804
us-gaap:CommonClassAMember
2024-08-19
2024-08-19
0002019804
hondu:RedeemablePublicWarrantMember
2024-08-19
2024-08-19
0002019804
hondu:PublicWarrantsMember
us-gaap:IPOMember
2024-08-19
0002019804
hondu:PublicWarrantsMember
2024-08-19
0002019804
2024-08-19
2024-08-19
0002019804
2024-08-19
0002019804
us-gaap:WarrantMember
us-gaap:CommonClassAMember
2024-09-30
0002019804
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2024-04-04
2024-09-30
0002019804
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2024-09-30
0002019804
us-gaap:WarrantMember
2024-04-04
2024-09-30
0002019804
us-gaap:WarrantMember
2024-09-30
0002019804
us-gaap:PrivatePlacementMember
2024-04-04
2024-09-30
0002019804
hondu:PrivatePlacementWarrantsMember
hondu:SponsorMember
2024-09-30
0002019804
hondu:PrivatePlacementWarrantsMember
hondu:CantorFitzgeraldCoMember
2024-09-30
0002019804
hondu:FounderSharesMember
2024-04-08
2024-04-08
0002019804
hondu:SponsorMember
hondu:FounderSharesMember
2024-04-08
0002019804
hondu:SponsorMember
hondu:FounderSharesMember
2024-04-08
2024-04-08
0002019804
hondu:FounderSharesMember
hondu:UnderwritersMember
2024-04-08
2024-04-08
0002019804
2024-04-08
2024-04-08
0002019804
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
us-gaap:CommonClassAMember
2024-04-04
2024-09-30
0002019804
srt:MinimumMember
2024-04-04
2024-09-30
0002019804
srt:MaximumMember
2024-04-04
2024-09-30
0002019804
hondu:AdministrativeServicesAgreementMember
2024-08-15
2024-08-15
0002019804
hondu:AdministrativeServicesAgreementMember
2024-04-04
2024-09-30
0002019804
us-gaap:OverAllotmentOptionMember
2024-04-04
2024-09-30
0002019804
hondu:UnderwriterAgreementMember
us-gaap:IPOMember
2024-08-19
0002019804
hondu:UnderwriterAgreementMember
us-gaap:IPOMember
2024-09-30
0002019804
us-gaap:OverAllotmentOptionMember
2024-09-30
0002019804
hondu:SponsorMember
us-gaap:CommonClassBMember
2024-04-04
2024-09-30
0002019804
hondu:SponsorMember
2024-04-04
2024-09-30
0002019804
hondu:SponsorMember
2024-09-30
0002019804
us-gaap:FairValueInputsLevel1Member
2024-09-30
0002019804
us-gaap:FairValueInputsLevel3Member
us-gaap:CommonClassAMember
2024-08-19
2024-08-19
0002019804
us-gaap:MeasurementInputSharePriceMember
2024-08-19
0002019804
us-gaap:MeasurementInputExercisePriceMember
2024-08-19
0002019804
us-gaap:MeasurementInputExpectedTermMember
2024-08-19
0002019804
us-gaap:MeasurementInputRiskFreeInterestRateMember
2024-08-19
0002019804
us-gaap:MeasurementInputPriceVolatilityMember
2024-08-19
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
In connection with the Quarterly Report of HCM
II Acquisition Corp (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2024, as filed with the Securities
and Exchange Commission (the “Report”), I, Shawn Matthews, Chairman and Chief Executive Officer, certify, pursuant to 18
U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
In connection with the Quarterly Report of HCM
II Acquisition Corp (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2024, as filed with the Securities
and Exchange Commission (the “Report”), I, Steven Bischoff, Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge: